CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...
CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...
European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
Biogen Idec BIIB today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like ...
Under the clarification, only Medicare beneficiaries going to a doctor's office for an Avonex injection once a week are eligible for reimbursement. Medicare will not cover three other injectable drugs ...
CAMBRIDGE, MA – April 15, 2008 -- Results of a phase IV, open label, head-to-head study of intramuscular AVONEX and high-dose, high-frequency subcutaneous Rebif® (interferon beta-1a) provide clinical ...
Serono SA released impressive 24-week data from its 677-patient, head-to-head study of its product Rebif vs. Biogen Inc. s Avonex in patients with relapsing-remitting multiple sclerosis, and is ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...
Avonex (interferon beta-1a) may not be safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. »Learn more about Avonex, including ...
PHILADELPHIA, Dec. 20, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that the Company has entered into an agreement with GP Pharm ...
Conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas are localized low-grade extra-nodal tumours that are managed with radiotherapy, cryotherapy, surgical excision, or even observation. A ...